Concepedia

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

Gut · 2003 · 910 citations · 36 references

Open access

Abstract

The once daily high dose probiotic VSL#3 is effective in maintaining antibiotic introduced remission for at least a year in patients with recurrent or refractory pouchitis. This is associated with a high level of quality of life.

References

36

Interleukin-10-deficient mice develop chronic enterocolitis

Ralf Kühn, Jürgen Löhler, D Rennick et al. · Cell · 1993 · 4.3K citations

Inflammation, Cytokine, Autoimmune Disease +6

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial

Paolo Gionchetti, Fernando Rizzello, Alessandro Venturi et al. · Gastroenterology · 2000 · 1.5K citations

Antimicrobial Stewardship, Oral Bacteriotherapy, Respiratory Infection +6

Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice

Rance K. Sellon, Susan L. Tonkonogy, Michael Schultz et al. · Infection and Immunity · 1998 · 1.5K citations · Full text

A New Measure of Health Status for Clinical Trials in Inflammatory Bowel Disease

Alba Mitchell, E. Jan Irvine, Joel Singer et al. · Gastroenterology · 1989 · 1.2K citations · Full text

Epidemiology, Functional Gastrointestinal Disorder, New Measure +9

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

Paolo Gionchetti, Fernando Rizzello, Ulf Helwig et al. · Gastroenterology · 2003 · 1.1K citations · Full text

Probiotic, Dysbiosis, Antimicrobial Susceptibility +8